Medisafe has been selected as a finalist in the Most Valuable Digital Therapy for Pharma category in the Reuters Pharma Awards 2022. Medisafe was selected among over 700 submissions due to its innovative approach to medication management and joins the ranks of other leading pharma organizations including Sanofi, Merck, Biogen, Takeda, and others in this prestigious award.

The final winners are set to be announced on December 1, 2022, in Philadelphia.